米非司酮联合米索前列醇用于瘢痕子宫中期妊娠引产临床观察

Clinical Observation of Mifepristone Combined with Misoprostol for Termination of Mid-pregnancy Abortion in Uterine Scar

目的:探讨米非司酮联合米索前列醇用于瘢痕子宫中期妊娠引产的临床效果。方法:选择我院瘢痕子宫妊娠自愿要求引产孕妇90例,本组患者行米非司酮联合米索前列醇药物引产。观察本组患者引产情况。结果:引产成功共88例,引产成功率为97.8%。单次给药引产成功率为84.4%,米索前列醇不良反应发生率为不良反应发生率为16.7%。结论:米非司酮联合米索前列醇用于瘢痕子宫中期妊娠引产临床效果显著,值得借鉴。

Objective：To investigate the effects of mifepristone combined with misoprostol in termination of Mid-pregnancy abortion in uterine scar.Methods：Choice of 90 cases of uterine scar pregnancy volunteered to induction of mifepristone combined with misoprostol for induction of labor in pregnant women.Observed in this group of patients induced condition.Results：The success of 88 cases,the success rate is 97.8%.The single delivery success rate was 84.4%,the incidence of adverse reactions of misoprostol for adverse reactions occurred at a rate of 16.7%.Conclusion：Mifepristone combined with misoprostol for termination of Mid-pregnancy abortion in uterine scar clinical effect,be worth to advocate.